Androgen induced oxidative stress inhibitors
US9023837B2 · kind B2 · utility
0Cited by
0References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 15, 2011 |
| Grant date | May 5, 2015 |
| Priority date | — |
| Expiry date | Apr 15, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Described herein are pharmaceutical compositions and medicaments, and methods of using such pharmaceutical compositions and medicaments in the treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.